NCT04861688 - NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

February 14, 2023

Study Completion Date

February 14, 2023

Conditions

Traumatic Brain Injury

Interventions

COMBINATION_PRODUCT

Traditional Chinese Medicine (NeuroAiD II™ (MLC901)

NeuroAiD II™ (MLC901) contains the extracts of 9 botanical active ingredients blended with commonly used excipients. The 9 botanical active ingredients are traditional herbs well documented in the Pharmacopoeia of the People's Republic of China.

OTHER

Placebo

Placebo with same appearance as active intervention

Trial Locations (4)

603126

Nizhny Novgorod regional clinical hospital named after N. A. Semashko, Nizhny Novgorod

Unknown

State Novosibirsk Regional Clinical Hospital, Novosibirsk

Municipal Polyclinic № 106 of St.Petersburg, Saint Petersburg

X7 Research, Saint Petersburg

All Listed Sponsors

lead

Moleac Pte Ltd.

INDUSTRY